JLE

Néphrologie & Thérapeutique

MENU

Access to kidney transplantation for patients with end-stage renal failure in Maghreb countries: state of art and recommendations Volume 20, issue 1, February 2024

Figures


  • Figure 1

  • Figure 2

Tables

Authors
1 Agence de la biomédecine, La Plaine Saint-Denis, France
2 Hôpital Charles Nicolle, service de médecine interne A, Tunis, Tunisie
3 Experte à l’Agence nationale des greffes, Centre régional médico-chirurgical, Blida, Algérie
4 CHU Mohamed V, service de néphrologie, hémodialyse et transplantation rénale, Marrakech, Maroc
5 Hôpital Charles Nicolle, service d’immunologie, Tunis, Tunisie
6 Institut Pasteur d’Algérie, Faculté de pharmacie d’Alger, Algérie
7 CHU Mohamed V, service d’anesthésie réanimation, Marrakech, Maroc
8 Hôpital Mongi Slim, service de chirurgie viscérale, Sidi Daoud La Marsa, Tunis, Tunisie
9 Hôpital La Rabta, service de chirurgie cardiovasculaire, Jebbari, Tunis, Tunisie
10 Centre national pour la promotion de la transplantation d’organes (CNPTO), Bab Saadoun, Tunis, Tunisie
11 CHU de Bab el Oued, service d’immunologie, Algérie
* Correspondance : MA. Macher <mariealice.macher@gmail.com>

We present an overview of kidney transplantation activity in the Maghreb countries, based on data from the 9th Colloque France-Maghreb (Paris, May 20 and 21, 2022). For Algeria, Morocco and Tunisia, the incidence of end stage renal failure is respectively 120, 130 and 130 per million inhabitants, its prevalence 626, 900 and 833 per million inhabitants and the part of patients with a functional graft of 10.3, 1.8 et 8.5% with an annual number of transplants of 6.5, 0.8 and 8.7 per million inhabitants. Living donor transplants account for 99% of transplants in Algeria, 93% in Morocco and 80% in Tunisia. In conclusion, access to transplantation remains low in the Maghreb countries. All the modalities (living donor with enlargement of the circle of donors, deceased donors) must be further developed. Recommendations were issued to support activity.